"Current PER at the Lowest Level... Expected to Reach 380,000 Won" Growth Potential Rises with U.S. Expansion [Weekend Money]
Hugel Draws Attention with Entry into U.S. Toxin Business
"Direct Sales Price 3 to 4 Times Higher than Other Regions
Direct Sales Revenue Set to Scale Up Rapidly in 2027"
It has been analyzed that Hugel, which has entered the U.S. toxin business, is expected to grow based on its high sales price.
Researcher Eun Ae Cho at IBK Investment & Securities stated, "Hugel's direct sales price in the United States is about twice as high as that of the existing U.S. indirect sales channels, and about three to four times higher than other export regions." She added, "Since Hugel is accelerating the establishment of its direct sales network and commencement of sales, this marks a period when expectations and visibility for the mid- to long-term growth potential of the U.S. business are increasing."
Hugel's U.S. toxin business is expected to gain full momentum in the second half of this year. Starting then, the accumulation of multiple clinical and local field data will begin, and the second half of 2027—the second full year—is projected to be when direct sales revenue experiences significant growth.
Researcher Cho said, "We assumed Hugel's U.S. market share would rise from 3% last year to 10% in 2028, with the proportion of direct sales increasing from 0% to 90% over the same period. Reflecting this, U.S. sales are projected to reach 75.6 billion won this year, 144.8 billion won next year, and 221.8 billion won in 2028, implying nearly twofold annual growth."
Hugel has set guidance of achieving a 10% market share in the U.S. by 2028, with combined direct and indirect sales totaling 270 billion won.
The investment opinion is "Buy," with a target price of 380,000 won. Researcher Cho noted, "Hugel's current share price is at the lower end of its price-earnings ratio (PER) band for the past two years, reflecting concerns over heightened competition and increased costs across the aesthetic device industry."
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
She added, "From now on, attention should shift from quarterly results to mid- to long-term growth strategy via direct sales in the U.S. and the potential for structural margin improvement. When the direct sales performance becomes evident in the numbers, a revaluation of Hugel's valuation should be possible."
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.